Item request has been placed!
×
Item request cannot be made.
×
Processing Request
10 State Medicaid Programs Include Pheburane for Urea Cycle Disorders.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Additional Information
- Subject Terms:
- Subject Terms:
- Abstract:
The article reports on the inclusion of Pheburane, an oral pellet formulation of sodium phenylbutyrate developed by Lucane Pharma and licensed to Medunik USA, to drug lists of four state Medicaid programs such as Georgia, Tennessee, Indiana, and Missouri, which brings the number of states to include Pheburane to ten. Topics include information on pheburane, wholesale acquisition cost of Pheburane, and a patient program offered by Medunik.
No Comments.